COVI-DROPS Enter Human Study to Fight Mild Cases of COVID-19
Sorreto Therapeutics recently announced through Globe Newswire that it has filed an application for its investigational new drug COVI-DROPS (STI-2099). The study will investigate the safety and efficacy of the…